Style | Citing Format |
---|---|
MLA | Esmaeili T, et al.. "Rivaroxaban Population Pharmacokinetic and Pharmacodynamic Modeling in Iranian Patients." Journal of Clinical Pharmacy and Therapeutics, vol. 47, no. 8, 2022, pp. 1284-1292. |
APA | Esmaeili T, Rezaee M, Abdar Esfahani M, Davoudian A, Omidfar D, Rezaee S (2022). Rivaroxaban Population Pharmacokinetic and Pharmacodynamic Modeling in Iranian Patients. Journal of Clinical Pharmacy and Therapeutics, 47(8), 1284-1292. |
Chicago | Esmaeili T, Rezaee M, Abdar Esfahani M, Davoudian A, Omidfar D, Rezaee S. "Rivaroxaban Population Pharmacokinetic and Pharmacodynamic Modeling in Iranian Patients." Journal of Clinical Pharmacy and Therapeutics 47, no. 8 (2022): 1284-1292. |
Harvard | Esmaeili T et al. (2022) 'Rivaroxaban Population Pharmacokinetic and Pharmacodynamic Modeling in Iranian Patients', Journal of Clinical Pharmacy and Therapeutics, 47(8), pp. 1284-1292. |
Vancouver | Esmaeili T, Rezaee M, Abdar Esfahani M, Davoudian A, Omidfar D, Rezaee S. Rivaroxaban Population Pharmacokinetic and Pharmacodynamic Modeling in Iranian Patients. Journal of Clinical Pharmacy and Therapeutics. 2022;47(8):1284-1292. |
BibTex | @article{ author = {Esmaeili T and Rezaee M and Abdar Esfahani M and Davoudian A and Omidfar D and Rezaee S}, title = {Rivaroxaban Population Pharmacokinetic and Pharmacodynamic Modeling in Iranian Patients}, journal = {Journal of Clinical Pharmacy and Therapeutics}, volume = {47}, number = {8}, pages = {1284-1292}, year = {2022} } |
RIS | TY - JOUR AU - Esmaeili T AU - Rezaee M AU - Abdar Esfahani M AU - Davoudian A AU - Omidfar D AU - Rezaee S TI - Rivaroxaban Population Pharmacokinetic and Pharmacodynamic Modeling in Iranian Patients JO - Journal of Clinical Pharmacy and Therapeutics VL - 47 IS - 8 SP - 1284 EP - 1292 PY - 2022 ER - |